tm logo
SPLEEN TO SCREEN
Live/Registered
REGISTERED

on 13 Aug 2019

Last Applicant/ Owned by

Yalelaan 62

NL

Serial Number

79227419 filed on 21st Jul 2017

Registration Number

5830546 registered on 13th Aug 2019

in the Principal Register

Correspondent Address

Peter Silverman

Peter Silverman Merus N.V.

Suite 302,

Cambridge, MA 02412

UNITED STATES

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

SPLEEN TO SCREEN

Services of biochemists, namely, scientific and medical laboratory services in the nature of efficient screening of antibodies in the nature of protein mixtures for the generation of mono and multispecific biologics; services of bacteriologic and biochemical laboratories, namely, research in the field of biochemistry; professional advice relating to biochemistry; conducting scientific and industri Read More

Classification Information


Class [045]
Personal & Legal & Social Services


Legal services; legal services relating to exploitation of intellectual property rights; licensing of intellectual property rights; legal advisory services in the aforementioned fields, namely, exploitation of intellection property rights and licensing of intellectual property rights, concerning rapid screening of panels of target-specific antibodies for the downstream production of, and for the manufacture of, mono and multispecific biologics in the fields of immuno-oncology and auto-immune diseases


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [044]
Medical, Beauty & Agricultural Services


Medical services; veterinary services; genetic testing of research animals, in particular of transgenic mice for research purposes


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [042]
Computer & Software Services & Scientific Services


Services of biochemists, namely, scientific and medical laboratory services in the nature of efficient screening of antibodies in the nature of protein mixtures for the generation of mono and multispecific biologics; services of bacteriologic and biochemical laboratories, namely, research in the field of biochemistry; professional advice relating to biochemistry; conducting scientific and industrial research using laboratory techniques, namely, the extraction, fragmentation, cloning, transformation, isolation, concatenation, complementing, selection, identification and compilation of cells and genetic materials in the nature of DNA and preparing related professional reports; professional advice relating to scientific and industrial research using laboratory techniques, namely, the extraction, fragmentation, cloning, transformation, isolation, concatenation, complementing, selection, identification and compilation of cells and genetic materials in the nature of DNA and the preparation of related professional reports; reviewing and analyzing anti-bodies in the nature of protein mixtures used in the medical and pharmaceutical industry and in science and the preparation of related professional reports for scientists, engineers, analysts and laboratory assistants and technicians for industry and government services; scientific and industrial research, in particular in the field of the aforementioned anti-bodies, namely, anti-bodies in the nature of protein mixtures; research and development of new products for others, in particular anti-bodies in the nature of protein mixtures; chemical and laboratory research services, namely, performing extraction, fragmentation, cloning, transformation, isolation, concatenation, complementing, selection, identification and compilation of cells and genetic materials in the nature of DNA and the preparation of related professional reports; consultancy relating to chemical and laboratory research services, namely, the performance of extraction, fragmentation, cloning, transformation, isolation, concatenation, complementing, selection, identification and compilation of cells and genetic materials in the nature of DNA and the preparation of related professional reports


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Pharmaceutical and veterinary preparations prepared with antibodies in the nature of protein mixtures used in the medical and pharmaceutical industry and in science for the treatment of cancer and other therapeutic indications, namely, for the generation of mono and multispecific biologics being biological preparations in the fields of immuno-oncology and auto-immune diseases


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [001]
Chemical Products


Biochemical products used in the medical and pharmaceutical industry and in science, in particular antibodies in the nature of protein mixtures for rapidly screening panels of target-specific antibodies for the downstream production of, and for the manufacture of, mono and multispecific biologics being biological preparations in the fields of immuno-oncology and auto-immune diseases


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 79227419

Mark Type

No Service Mark

Attorney Docket Number

No 11137T00040U

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
13th Aug 2024COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
30th Jul 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
30th Jul 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
30th Jul 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
30th Jul 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
30th Jul 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
30th Jul 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
30th Jul 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
13th Dec 2019FINAL DECISION TRANSACTION PROCESSED BY IB
26th Nov 2019FINAL DISPOSITION NOTICE SENT TO IB